Affiliation:
1. Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-84606, USA
2. Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT-84606, USA.
Abstract
Abstract:
Coronavirus disease-19 (COVID-19), a serious pandemic due to the SARS-CoV-2 virus
infection, caused significant lockdowns, healthcare shortages, and deaths worldwide. The infection
leads to an uncontrolled systemic inflammatory response causing severe respiratory distress and
multiple-organ failure. Quick development of several vaccines efficiently controlled the spread of
COVID-19. However, the rise of various new subvariants of COVID-19 demonstrated some concerns
over the efficacy of existing vaccines. Currently, better vaccines to control these variants are
still under development as several new subvariants of COVID-19, such as omicron BA-4, BA-5, and
BF-7 are still impacting the world. Few antiviral treatments have been shown to control COVID-19
symptoms. Further, control of COVID-19 symptoms has been explored with many natural and synthetic
adjuvant compounds in hopes of treating the deadly and contagious disease. Vitamins have
been shown to modulate the immune system, function as antioxidants, and reduce the inflammatory
response. Recent studies have investigated the potential role of vitamins, specifically vitamins A, B,
C, D, and E, in reducing the immune and inflammatory responses and severity of the complication.
In this brief article, we discussed our current understanding of the role of vitamins in controlling
COVID-19 symptoms and their potential use as adjuvant therapy.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine